A novel, solid phase, enzyme immunoassay for the measurement of human plasma follicle stimulating hormone has been developed. The method is a direct, competitive inhibition system of high precision and accuracy. It compares favourably with solid phase radioimmunoassay using the same antiserum and hormone preparations. Hormone reference values are presented for normal men, and for women at various stages in the menstrual cycle and in the menopausal state.
Many enzyme-antibody conjugates are easy to prenare by glutaraldehyde coupling reactions and are chemically stable (Avrameas, 1969) . The application of these additional compounds to solid phase immunoassay of proteins has been demonstrated by enzyme-linked immunosorbent techniques (Engvall and Perlmann, 1971) . Using alkaline phosphatase conjugated to sheep antirabbit IgG, Engvall and Perlmann (1972) have developed a method for the determination of antibodies using antigencoated polystyrene tubes. In this method, diluted antiserum was added to the coated tubes followed by conjugate; a competitive reaction occurred between the antibody species attracted towards antigen.
In the present work, a system has been developed for the estimation of human plasma follicle stimulating hormone (FSH) using antibody-coated tubes. Hormonal antigen and enzyme-anti-v-globulin conjugate compete together for solid phase antibody. The enzyme Is estimated colorimetrically. The method appears to be generally applicable to the assay of glycoprotein, and steroid hormones. and was also used for the BSA solution. STANDARDS FSH 69-104 was dissolved in phosphate buffer to give a strength of 200 U/U This was aliquotted into 1 ml quantities and stored at -18 0 • From this the following range of standards was made on the day of the assay using carbonate/bicarbonate buffer for the dilutions: 50, 20, 10, 5, 2,5, 0'5, and 0·25 U/l. A hormone blank was also prepared. NHP solutions were made by adding water (1220 Ill Engvall and Perlmann (1972) . A typical procedure is as follows.
The enzyme preparation was a suspension in 3·2 M ammonium sulphate, pH 7, stablised with 0·001 M magnesium chloride and 0·0001 M zinc chloride, of specific activity 1100 U/mg (5 mg protein/nil). The enzyme (I ml) was centrifuged at 2000 rpm for 10 minutes. The supernatant was discarded and the pellet was dissolved in sheep antirabbit-v-globulin (425 III of a solution in phosphate buffer, pH 7'4). The mixture was dialysed (Visking tubing type 18/32, the Scientific Instrument Co, London) against phosphate buffer, pH 7'4, for 24 hours at 18°(two changes of buffer). Glutaraldehyde (33 Ill) was added and after 2 hours at 18°, the mixture was redialysed over 24 hours and then sterilised by filtration.
The separation of the reaction products from IgG, free and dimerised enzyme, was readily achieved on a column of Sephadex G-200-120 (particle size 40-120 u, Sigma) which had been equilibrated with 0·05 M phosphate buffer, pH 7·4. The column was eluted with the same buffer, and the protein contents of 1 m1 fractions were measured by their absorbancy at 280 mil. The enzyme activity of the products before and after chromatography was estimated and the yield based on enzyme activity of active peaks was calculated. For measurement of activity a colorimetric method was used involving a p-nitrophenyl phosphate substrate. The enzyme hydrolyses bound phosphate and liberates yellow p-nitrophenolate. The increase in absorption with time is linear under the conditions described up to approximately one absorption unit. Comparison of absorption readings with a standard enzyme curve, using Lovesey dialysed purified enzyme of known protein content, provides enzymic activity estimation for the chromatography fractions. To each 1 ml fraction 1 ml of a solution of substrate (14 tablets of 5 mg Sigma 104 phosphatase substrate in 35 ml pH 10 carbonate/bicarbonate buffer) was added. Absorption readings were taken 100 minutes later, and activity was read off by comparison with the standard curve.
The fractions in the first protein peak eluted were combined and stored (after filtration sterilisation) at 4°and used as the preparation of alkaline phosphatase-sheep-antirabbit-y-globulin complex without further purification.
Molecular weight ranges for the chromatography peaks were estimated according to Whitaker (1963) . The void volume of the column was determined using blue dextran (Pharmacia). The exclusion limit was reached at MW 480000 (the MW of urease). Elution volumes for protein standards of xanthine oxidase, catalase, p-amylase, BSA, ovalbumin, and ribonuclease of known MW were estimated. A standard curve of VIV. versus IOg10 MW gives a straight line graph, where V is the elution volume of each protein and V. the void volume. The MW ranges for the chromatography peaks in the preparation of the enzyme label were read off from this standard curve. Purified dialysed alkaline phosphatase and antibody were also run through the column in order to compare their elution volumes with those of the chromatography peaks in the preparation.
TUdE COATING Assay tubes were coated with 2 ml aliquots (Lumix dispenser) of FSH antiserum diluted 1 :15 000 in carbonate/bicarbonate buffer, pH 10'0. After 24 hours at 18°the tubes were aspirated and washed three times with buffer, and 2 ml4 %BSA was added.
After a further 15 minutes at 18°the tubes were aspirated, washed three times with buffer, centrifuged, and aspirated to remove residual buffer. The tubes were stoppered and stored at 4°.
Assay method ENZYME-ANTIBODY CONJUGATE DILUTION
The strength of each new preparation of conjugate requires to be standardised for the assay. To find the volume, x, of first peak chromatography eluate that is required for use in the assay tubes, the following procedure is adopted. A series of solutions are made up: Label 6000, 5000, 4000, 3000, 2000, 1000, 250, and 50 Ill, diluted in pH 10 buffer to give total volumes of 7·5 ml. After mixing on a vortex mixer, the solutions are dispensed in 2 ml aliquots to triplicate series of antibody-coated tubes. After 18 hours at 18°, the tubes are aspirated, washed three times with buffer, stoppered, centrifuged, and re-aspirated, To each tube 2 m1 of substrate solution (same strength as indicated earlier) are added. After 100 minutes absorption, readings are taken and the graph of absorption versus amount of label is drawn up. The lowest value of the label volume corresponding to the linear part of the curve is determined. This gives the value of x, ASSAY PROCEDURE Solutions are prepared as follows:
Test/Standards 100 III Label solution
x III Buffer pH 10 7350 -x III for standards 7400 -x J,1l for tests.
Reconstituted NHP 50 III for standards only.
(It has been shown from previous solid-phase studies (Lovesey, 1980) , using coating antiserum M93 6873 diluted 1:15 000, that 50 III of NHP solution provides plasma inhibition equivalent to that of the mean plasma inhibition of test samples with low levels of endogenous hormone.) Two-millitre aliquots from each solution are dispensed to triplicate sets of coated tubes and also to one set of uncoated tubes as a check on nonspecific binding. The tubes are capped and left at 18°for 18 hours. The contents are aspirated and the tubes washed three times with buffer, capped, centrifuged, and re-aspirated, The enzyme activity is then assayed colorimetrically as described for label dilution estimation. Standard curves of absorption at 4051l1 versus log FSH concentration are drawn up and test plasma readings are compared with these.
ASSAY PERfORMANCE

Label binding
The antiserum dilution used was suggested from previous radioimmunoassay solid phase work (Lovesey, 1980) for the measurement of plasma FSH. To estimate the percent of enzyme label bound to antibody at the dilution used, activity determinations were made of label before and after tube coating.
Standard curve linearity
A series of absorption versus log FSH concentration curves were prepared from experiments using times of 20, 70, 100, ISO, and 200 minutes and a wide range (0-300 U/I) of FSH concentrations in order to test the extent of standard curve linearity.
Recovery studies
Varying amounts of hormone were added to a plasma sample with a low level of endogenous hormone, and mean recoveries (± standard deviation) were estimated.
Preclsion studies
Regular assays of three pooled plasma samples kept at -15°gave an indication of between-assay variation. Within-assay precision was calculated from triplicate assays of 100 separate samples.
Quality control
External quality control samples from the World Health Organisation QC scheme were analysed periodically, and the results were contrasted with the WHO mean assay figures derived from assay reports sent in from the centres participating in the QC scheme.
Results and discussion ENZYME LABEL PREPARATION
The yields based on enzyme activity measurements for active fractions in the preparation of alkaline phosphatase-antibody conjugate are given in Table 1 . Figure 1 shows the elution pattern for the G-200-120 Sephadex chromatography of the reaction products after coupling with glutaraldehyde. Four protein peaks were recorded, denoted 1-4 in the diagram, of which 1, 2, and 4 contained enzymic activity. Peak 4 corresponds to the elution range for free alkaline phosphatase. The MW, calculated according to the method of Whitaker (1963) (see Fig. 2 and Table 2 ), agrees with that given in the literature for alkaline phosphatase, that is 100 000 (Dixon and Webb, 1965) .
Peak 3 occurs at the elution range for free sheep antirabbit-v-globulin when put through the column. The calculated MW is in agreement with that given by Whitaker (1963) .
Peak 1 corresponds to a MW of 260 000. MWs of about 200 000-210 000 have been estimated for glutaraldehyde coupled enzyme-antibody complexes (Avrameas and Ternynck, 1971) . However, this can be only a minimum figure since the complexes are eluted at the void volume of the column. This low exclusion limit for the G-200 Sephadex can be raised by the use of larger particle size Sephadex (40-120 11), as in the present work. In addition, the value of 170000 reported by Avrameas and Ternynck (1971) for the antibody IgG appears to be high in relation to values of about 160 000 (Hum and Landon, 1971) , 156000 (Whitaker, 1963) , and 156000 in the present work.
The sum of the MWs of enzyme and antibody is 261 000. Peak 1 MW is thus in agreement with the MW' expected for a monomeric conjugate. Peak 2 (estimated MW 210 000 and enzymically active) is probably a result of enzyme dimers. Such compounds are formed in low yield in glutaraldehyde coupling of peroxidase to antibody (Avrameas and Ternynck, 1971) . illustrated in Fig. 4 , the absorption curves reach maximum values at FSH = 0 VjI. Where enough time is allowed (curves D and E) the absorption reaches a saturation plateau. LABEL CONCBNTRATION AND TRIPLICATE SCATTBR Figure 3 is a typical graph of the effect of label concentration on the level of absorption readings. Theresolution of the colorimeter is 0·001 absorbance unit, the stability being better than ± 0·005 absorbance unit after the 'warm-up' period. At ranges of label strength below that required for antibody saturation (in the absence of FSH) the curve loses linearity. The degree of scatter between triplicate readings (reflected in the standard deviation curves of Fig. 3 ) then becomes unacceptably high, as the slope of the graph becomes steeper for a given conjugate volume. The amount of conjugate used for the assay is therefore taken as the minimum value required for curve linearity. Higher values are also satisfactory but less economical in terms of label preparation. The minimum standard deviation attainable is ± 0·01 absorption unit.~; The effect of varying the period of substrate reaction in the colorimetric assay is given in Figure 4 . This set of graphs illustrates the competitive nature of the reaction between enzyme-antibody label and FSH for the coating antibody. At high concentrations of hormone the amount of label binding to solid phase antibody is considerably suppressed. Absorption readings tend towards minimum values indicated by the levelling off of the standard curves.
Vnder the conditions for the series of experiments
Best linearity is obtained after reaction times of 100 minutes (curve C), when the linearity range extends from 0'5-50 Vjl FSH. From 0·5 Vjl down to 0·25 Vjl the change in absorption produced is only 0·07 unit. Below 0·5 Vjl the slope of the standard curve (C) decreases, and there is significant interference in reading accuracy caused by the scatter between triplicate readings (twice the standard deviation of the scatter = 0·02 absorbance unit).
This type of solid phase enzyme immunoassay (direct, competitive, non-sequential inhibition system) for the measurement of FSH has not been described before in the literature. In gonadotrophin RIA it is often necessary to use sequential incubation of label after prior antigen incubation in order to lessen the effects of radiation damage, but because the enzyme label used in the present system is nonradioactive, direct incubation of label and antigen can take place together. Table 3 shows assay characteristics and data for solid phase RIA (Lovesey, 1980) and EIA of FSH using identical antiserum and hormone preparations. The results given in the columns clearly indicate that EIA compares favourably with RIA as regards accuracy and precision.
From triplicate assays of 100 human plasma samples (all different) the following reference values were obtained for FSH concentrations in normal men and women. The values presented in Table 4 are in good agreement with those cited in the literature (Wide et al., 1973; Lovesey, 1980) . The solid phase EIA described in the present work is therefore considered to be an accurate method suitable for the routine assay of human plasma FSH. It is fast and easy to operate. Precision is as good as in solid phase RIA, and the apparatus required for the assay is less costly than for RIA. The preparation of the enzyme label is straightforward. Initial studies on other glycoprotein and steroid hormones indicate that this particular method of direct competition between enzyme label and hormone for solid phase antibody has a wide general applicability. 
